The principal aim of the study is to avoid the diagnostic wanderings of patients suffering from a peroxisomal disorder. For this purpose, a new diagnostic strategy is proposed. It rests on functional metabolic explorations and gene studies directly connected to a first-line enlarged physico-chemical detection of metabolites from peroxisomal origin in clinically suspect patients.
Study Type
OBSERVATIONAL
Enrollment
8
Département de Pédiatrie, Unité de Génétique Clinique, CHU d'Amiens
Amiens, France
Pédiatrie, CHU Clémenceau de Caen
Caen, France
Hôpital Jeanne de Flandres, CHRU
Lille, France
Pédiatrie, Pavillon Mère et Enfant, CHU Ch. Nicolle de Rouen
Rouen, France
Percentage of cases diagnosed by the new procedure versus the number of patients included.
Evaluation of a diagnostic strategy based on functional metabolic explorations and gene studies directly connected to a first-line enlarged physico-chemical detection of metabolites from peroxisomal origin in clinically or biologically suspect patients The study is concomitant with an implementation in the routine Hospitals of the inter-region (West and North of France) of an immediate wide exploration (and not sequential and optional) of diagnostic markers of a pathology peroxisomal. This wide exploration should by itself lead to a diagnosis enrichment and should increase the number of inclusions. But the study, for patients thus included, is also considering an enlarged scanning of functional and genetic explorations that follow inclusion (instead of targeted screening guided primarily by the biological anomaly in the usual practice).
Time frame: 14 months
Number of new cases diagnosed by the new procedure in relation to the number of habitants per year.
Evaluation of a diagnostic strategy based on functional metabolic explorations
Time frame: 14 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.